1. Antireflux Versus Conventional Plastic Stent in Malignant Biliary Obstruction: A Prospective Randomized Study
- Author
-
Saija Hurme, Hanna Vihervaara, Paulina Salminen, Juha Grönroos, and Risto Gullichsen
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,Stent patency ,03 medical and health sciences ,0302 clinical medicine ,Neoplasms ,Clinical endpoint ,medicine ,Humans ,Plastic stent ,Prospective randomized study ,Prospective Studies ,cardiovascular diseases ,Aged ,ta3126 ,Aged, 80 and over ,Cholestasis ,business.industry ,Stent ,Middle Aged ,equipment and supplies ,Interim analysis ,Prosthesis Failure ,Surgery ,Jaundice, Obstructive ,surgical procedures, operative ,030220 oncology & carcinogenesis ,Early Termination of Clinical Trials ,Biliary stent ,Female ,Stents ,030211 gastroenterology & hepatology ,Obstructive jaundice ,Radiology ,business ,Plastics - Abstract
Objective: Endoscopic stents are used to relieve obstructive jaundice. The purpose of this prospective randomized study was to compare the patency of antireflux and conventional plastic biliary stent in relieving distal malignant biliary obstruction. Materials and Methods: All jaundiced patients admitted to hospital with suspected unresectable malignant distal biliary stricture between October 2009 and September 2010 were evaluated for the study. Eligible patients were randomized either to antireflux or conventional plastic stent arms. The primary endpoint was stent patency and the follow-up was continued either until the stent was occluded or until 6 months after the stent placement. Results: At an interim analysis, antireflux stents (ARSs; n = 6) had a significantly shorter median patency of 34 (8–49) days compared with the conventional stent (n = 7) patency of 167 (38–214) days (P = .0003). Based on these results, the study was terminated due to ethical concerns. Conclusion: According to these...
- Published
- 2017
- Full Text
- View/download PDF